
CAS 1803171-55-2
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Ravulizumab
CAS :<p>Ravulizumab (ALXN1210) is a humanized antibody for blocking complement activation, treating PNH, aHUS, and myasthenia gravis.</p>Degré de pureté :> 95%Couleur et forme :LiquidMasse moléculaire :145.80 kDaRavulizumab
CAS :Anti-Complement component 5 humanized monoclonal antibody; paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome treatment


